Related Experiment Video
Updated: Mar 20, 2026

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
Published on: December 16, 2016
Microarray data on altered transcriptional program of Phgdh-deficient mouse embryonic fibroblasts caused by ʟ-serine
Momoko Hamano1, Tomoko Sayano2, Wataru Kusada3
1Laboratory of Functional Genomics and Metabolism, Departments of Innovative Science and Technology for Bio-industry, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka 812-8581, Japan; International College of Arts and Sciences, Fukuoka Women׳s University, Fukuoka 813-8529, Japan.
Insights
Serine deficiency causes severe developmental issues and organ malformations. This study investigated the molecular basis of these growth defects by analyzing gene expression in cells lacking serine synthesis.
Area of Science:
- Biochemistry and Molecular Biology
- Developmental Biology
- Genomics
Background:
- Inborn errors of metabolism, specifically L-serine deficiency, lead to severe intrauterine growth retardation and multi-organ malformations, particularly affecting the central nervous system.
- These deficiencies can result in perinatal or early postnatal lethality in both human and mouse models.
- Understanding the molecular mechanisms behind these growth-arrested phenotypes is crucial for potential therapeutic interventions.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the growth-arrested phenotypes associated with L-serine deficiency.
- To compare gene expression profiles in cells with and without L-serine to identify key regulatory pathways.
Main Methods:
- Comparison of gene expression profiles using microarray analysis.
- Utilized mouse embryonic fibroblasts deficient in 3-phosphoglycerate dehydrogenase (Phgdh), the rate-limiting enzyme in de novo L-serine synthesis.
- Experimental conditions involved both L-serine-depleted and L-serine-supplemented media.
Main Results:
- Gene expression profiles were analyzed to identify molecular differences between L-serine-depleted and supplemented conditions.
- The study identified specific genes and pathways affected by the deficiency in de novo serine synthesis.
- Data are publicly available on Gene Expression Omnibus (GEO: GSE55687) for further research.
Conclusions:
- The study provides insights into the molecular basis of developmental defects caused by L-serine deficiency.
- Identifying affected gene expression patterns can pave the way for understanding the complex pathophysiology of serine deficiency disorders.
- The comprehensive gene expression data serves as a valuable resource for the scientific community studying serine metabolism and developmental biology.
Abstract:
Inherent ʟ-Ser deficiency culminates in intrauterine growth retardation, severe malformation of multiple organs particularly the central nervous system, and perinatal or early postnatal death in human and mouse. To uncover the molecular mechanisms underlying the growth-arrested phenotypes of l-Ser deficiency, we compared gene expression profiles of mouse embryonic fibroblasts deficient in 3-phosphoglycerate dehydrogenase (Phgdh), the first enzyme of de novo ʟ-Ser synthetic pathway, between ʟ-Ser-depleted and -supplemented conditions. The datasets (CEL and CHP files) from this study are publicly available on the Gene Expression Omnibus repository (accession number GEO: GSE55687).

